ANTX
An2 Therapeutics
$4.52
+$0.66 (+17.1%)Oct 28, 2026
Key metrics
The numbers that frame ANTX today
- Market cap
- $170.57M
- ROIC
- -106.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.00
- 52wk High
- $7.19
Growth
Revenue and earnings trend for ANTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ANTX
Is An2 Therapeutics a good buy?
Hold. An2 Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think An2 Therapeutics is selling at a very high price.
What is the market capitalization of ANTX?
An2 Therapeutics's market capitalization is $170.57M.
What is the 52-week high for ANTX stock?
The 52-week high for An2 Therapeutics is $7.19. The current close of $4.52 is 37.1% below that high.
What is the 52-week low for ANTX stock?
The 52-week low for An2 Therapeutics is $1.00. The current close of $4.52 is 352% above that low.
Does ANTX stock pay dividends?
An2 Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ANTX?
An2 Therapeutics's Debt / Equity ratio is 0.